.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Baxter
Julphar
Mallinckrodt
Novartis
Fish and Richardson
Queensland Health
Harvard Business School
Deloitte
US Army

Generated: September 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 072206

« Back to Dashboard
NDA 072206 describes LOXAPINE SUCCINATE, which is a drug marketed by Watson Labs, Mylan, Elite Labs Inc, and Lannett Holdings Inc, and is included in seven NDAs. It is available from ten suppliers. Additional details are available on the LOXAPINE SUCCINATE profile page.

The generic ingredient in LOXAPINE SUCCINATE is loxapine succinate. There are eight drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the loxapine succinate profile page.

Summary for NDA: 072206

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Antipsychotics
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 072206

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LOXAPINE SUCCINATE
loxapine succinate
CAPSULE;ORAL 072206 ANDA Actavis Pharma, Inc. 0591-0371 0591-0371-01 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-0371-01)
LOXAPINE SUCCINATE
loxapine succinate
CAPSULE;ORAL 072206 ANDA REMEDYREPACK INC. 70518-0347 70518-0347-0 30 CAPSULE in 1 BLISTER PACK (70518-0347-0)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrengthEQ 25MG BASE
Approval Date:Jun 15, 1988TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Merck
Fuji
UBS
AstraZeneca
Fish and Richardson
Farmers Insurance
Boehringer Ingelheim
Express Scripts
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot